164 related articles for article (PubMed ID: 27229773)
21. Purification of recombinant adeno-associated virus vectors by column chromatography and its performance in vivo.
Gao G; Qu G; Burnham MS; Huang J; Chirmule N; Joshi B; Yu QC; Marsh JA; Conceicao CM; Wilson JM
Hum Gene Ther; 2000 Oct; 11(15):2079-91. PubMed ID: 11044910
[TBL] [Abstract][Full Text] [Related]
22. Production and Purification of Adeno-Associated Viral Vectors (AAVs) Using Orbitally Shaken HEK293 Cells.
Gaudry JP; Aebi A; Valdés P; Schneider BL
Methods Mol Biol; 2024; 2810():55-74. PubMed ID: 38926272
[TBL] [Abstract][Full Text] [Related]
23. Comparison of retroviral and adeno-associated viral vectors designed to express human clotting factor IX.
Chen L; Perlick H; Morgan RA
Hum Gene Ther; 1997 Jan; 8(2):125-35. PubMed ID: 9017417
[TBL] [Abstract][Full Text] [Related]
24. Production of recombinant adeno-associated viral vectors using a baculovirus/insect cell suspension culture system: from shake flasks to a 20-L bioreactor.
Meghrous J; Aucoin MG; Jacob D; Chahal PS; Arcand N; Kamen AA
Biotechnol Prog; 2005; 21(1):154-60. PubMed ID: 15903253
[TBL] [Abstract][Full Text] [Related]
25. Large-scale clinical-grade retroviral vector production in a fixed-bed bioreactor.
Wang X; Olszewska M; Qu J; Wasielewska T; Bartido S; Hermetet G; Sadelain M; Rivière I
J Immunother; 2015 Apr; 38(3):127-35. PubMed ID: 25751502
[TBL] [Abstract][Full Text] [Related]
26. Scalable production of adeno-associated virus type 2 vectors via suspension transfection.
Park JY; Lim BP; Lee K; Kim YG; Jo EC
Biotechnol Bioeng; 2006 Jun; 94(3):416-30. PubMed ID: 16622883
[TBL] [Abstract][Full Text] [Related]
27. Standardized, Scalable, and Timely Flexible Adeno-Associated Virus Vector Production Using Frozen High-Density HEK-293 Cell Stocks and CELLdiscs.
Strobel B; Zuckschwerdt K; Zimmermann G; Mayer C; Eytner R; Rechtsteiner P; Kreuz S; Lamla T
Hum Gene Ther Methods; 2019 Feb; 30(1):23-33. PubMed ID: 30693792
[TBL] [Abstract][Full Text] [Related]
28. Manufacturing of recombinant adeno-associated viruses using mammalian expression platforms.
Robert MA; Chahal PS; Audy A; Kamen A; Gilbert R; Gaillet B
Biotechnol J; 2017 Mar; 12(3):. PubMed ID: 28177193
[TBL] [Abstract][Full Text] [Related]
29. Gene therapy for hemophilia B mice with scAAV8-LP1-hFIX.
Lu W; Zhou Q; Yang H; Wang H; Gu Y; Shen Q; Xue J; Dong X; Chen J
Front Med; 2016 Jun; 10(2):212-8. PubMed ID: 27052253
[TBL] [Abstract][Full Text] [Related]
30. High-titer recombinant adeno-associated virus production utilizing a recombinant herpes simplex virus type I vector expressing AAV-2 Rep and Cap.
Conway JE; Rhys CM; Zolotukhin I; Zolotukhin S; Muzyczka N; Hayward GS; Byrne BJ
Gene Ther; 1999 Jun; 6(6):986-93. PubMed ID: 10455400
[TBL] [Abstract][Full Text] [Related]
31. [Quality control of recombinant adeno-associated virus type 2/human blood coagulation factor IX].
Gao K; Wang JZ; Rao CM; Wu XB
Yao Xue Xue Bao; 2003 Sep; 38(9):684-9. PubMed ID: 14730919
[TBL] [Abstract][Full Text] [Related]
32. Scalable purification of adeno-associated virus serotype 1 (AAV1) and AAV8 vectors, using dual ion-exchange adsorptive membranes.
Okada T; Nonaka-Sarukawa M; Uchibori R; Kinoshita K; Hayashita-Kinoh H; Nitahara-Kasahara Y; Takeda S; Ozawa K
Hum Gene Ther; 2009 Sep; 20(9):1013-21. PubMed ID: 19534598
[TBL] [Abstract][Full Text] [Related]
33. Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors.
Snyder RO; Miao CH; Patijn GA; Spratt SK; Danos O; Nagy D; Gown AM; Winther B; Meuse L; Cohen LK; Thompson AR; Kay MA
Nat Genet; 1997 Jul; 16(3):270-6. PubMed ID: 9207793
[TBL] [Abstract][Full Text] [Related]
34. High-titer, serum-free production of adeno-associated virus vectors by polyethyleneimine-mediated plasmid transfection in mammalian suspension cells.
Hildinger M; Baldi L; Stettler M; Wurm FM
Biotechnol Lett; 2007 Nov; 29(11):1713-21. PubMed ID: 17636388
[TBL] [Abstract][Full Text] [Related]
35. Transient transfection methods for clinical adeno-associated viral vector production.
Wright JF
Hum Gene Ther; 2009 Jul; 20(7):698-706. PubMed ID: 19438300
[TBL] [Abstract][Full Text] [Related]
36. Combination of baculovirus-mediated gene delivery and packed-bed reactor for scalable production of adeno-associated virus.
Huang KS; Lo WH; Chung YC; Lai YK; Chen CY; Chou ST; Hu YC
Hum Gene Ther; 2007 Nov; 18(11):1161-70. PubMed ID: 17944574
[TBL] [Abstract][Full Text] [Related]
37. Functions of AAV-CMV-F.IX And AAV-EF1alpha-F.IX in gene therapy for hemophilia B.
Wiwanitkit V
Hum Gene Ther; 2007 Feb; 18(2):89-92. PubMed ID: 17266422
[TBL] [Abstract][Full Text] [Related]
38. Development of packaging cell lines for generation of adeno-associated virus vectors by lentiviral gene transfer of trans-complementary components.
Nakamura S; Nakamura R; Shibata K; Kobayashi M; Sahara N; Shigeno K; Shinjo K; Naito K; Ohnishi K; Kasahara N; Iwaki Y
Eur J Haematol; 2004 Oct; 73(4):285-94. PubMed ID: 15347316
[TBL] [Abstract][Full Text] [Related]
39. Development of a scalable process for high-yield lentiviral vector production by transient transfection of HEK293 suspension cultures.
Ansorge S; Lanthier S; Transfiguracion J; Durocher Y; Henry O; Kamen A
J Gene Med; 2009 Oct; 11(10):868-76. PubMed ID: 19618482
[TBL] [Abstract][Full Text] [Related]
40. Transfection-free and scalable recombinant AAV vector production using HSV/AAV hybrids.
Booth MJ; Mistry A; Li X; Thrasher A; Coffin RS
Gene Ther; 2004 May; 11(10):829-37. PubMed ID: 14985784
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
